|
FDA Clears Evolva's IND For EV-077 In Influenza
Medical News Today (press release) Evolva Holding SA (SIX: EVE) today announced that the US Food and Drug Administration (FDA) has cleared Evolva's request to test EV-077 in man, under an Investigational New Drug (IND) application for influenza. Neil Goldsmith, CEO and Managing Director ... |
Read the full story:
FDA Clears Evolva's IND For EV-077 In Influenza - Medical News Today (press release)
You must log in to post a comment.